Brain Cancer Trial, Recruiting NCT02914067 Sponsor: Washington University School of Medicine Condition: Brain Cancer
Back to Brain Cancer

Brain Cancer Trial, Recruiting

NCT02914067
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Cohort 1 – Newly diagnosed brain tumor (up to 30 participants)

  • Children and young people aged 4 to 18 years old
  • Recently diagnosed with a primary brain tumor of any type or location
  • Expected to live for at least one year
  • Able to understand the study and willing to agree to take part, with a parent or guardian's agreement if required

Cohort 2 – Posterior fossa brain tumor (up to 150 participants)

  • Children and young people aged 4 to 18 years old
  • Previously diagnosed with a brain tumor in the lower back part of the brain (called the posterior fossa), whether currently receiving treatment or having already finished treatment
  • Expected to live for at least one year
  • Able to understand the study and willing to agree to take part, with a parent or guardian's agreement if required

Cohort 3 – Posterior fossa syndrome (up to 20 participants)

  • Children and young people aged 4 to 18 years old
  • Previously diagnosed with a brain tumor in the lower back part of the brain (posterior fossa)
  • Diagnosed with a condition called posterior fossa syndrome after surgery (a condition that can affect speech, movement, and behaviour following certain brain surgeries)
  • Unable to complete a specific set of computer-based tests called the NIH Toolbox
  • Expected to live for at least one year
  • Able to understand the study and willing to agree to take part, with a parent or guardian's agreement if required

Cohort 4 – Long-term follow-up (up to 50 participants)

  • People aged 12 to 30 years old
  • Diagnosed with a brain tumor more than 3 years before joining the study
  • Expected to live for at least one year
  • Able to complete a 1-hour MRI scan without needing sedation (medication to make someone drowsy or sleep)
  • Able to understand the study and willing to agree to take part, with a parent or guardian's agreement if required

Who may not be able to join:

Cohorts 1 and 2

  • People whose vision is impaired to the point where completing computer-based tests would not be possible
  • People who are unable to have an MRI scan for medical reasons, such as having a cardiac pacemaker (a device implanted in the chest to help the heart beat)
  • People who have a programmable shunt (a device implanted in the brain to drain fluid, with adjustable settings) — this applies to Cohort 1 only

Cohort 3

  • People who are unable to have an MRI scan for medical reasons, such as having a cardiac pacemaker

Cohort 4

  • People who are unable to have an MRI scan for medical reasons, such as having a cardiac pacemaker
  • People who wear dental braces or have a programmable shunt
  • People who require sedation in order to undergo an MRI scan

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Stephanie Perkins, M.D., Washington University School of Medicine

Phone: 314-273-2931

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
26 October 2016
Est. completion
30 November 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Identify reliable peri-diagnostic estimators of cognition as measured by neurocognitive testing; Identify reliable peri-diagnostic estimators of cognition as measured by advanced resting-state functional connectivity MRI (rsfcMRI) data; Predictors of cognitive recovery in children as determined by multiplexed analyses of a combination of potential biomarkers across multiple modalities (rsfcMRI, structural MRI, NIH Toolbox, patient demographics, treatment information); Identify reliable peri-diagnostic estimators of brain function as measured by neurocognitive testing; Identify reliable peri-di...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov